Offerings // Immix Biopharma, Inc.

IMMX offering history

Every offering-related filing in Immix Biopharma, Inc.’s recent SEC record — registrations (announced capacity) kept separate from pricing documents (executed sales). Reviewed 244 filings back to Jul 20, 2021.

Last executed offering

Sep 29, 2026

424B5 — priced deal (shares or notes)

Last registration (announced)

Jan 9, 2026

S-3 — capacity, not a sale

Executed, last 12 months

424B pricings + 8-K 3.02 sales

Registered, last 12 months

S-1/S-3/F-series registrations

Date	Filing		What it means
Sep 29, 2026	424B5 →	EXECUTED	Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Sep 29, 2026	FWP →	MARKETING	Free-writing prospectus — offering being marketed
May 21, 2026	FWP →	MARKETING	Free-writing prospectus — offering being marketed
May 21, 2026	424B5 →	EXECUTED	Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Mar 25, 2026	424B5 →	EXECUTED	Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Jan 22, 2026	EFFECT →	EFFECTIVE	SEC declared a registration effective — selling can begin
Jan 9, 2026	S-3 →	REGISTERED	S-3 registration — capacity to sell shares, not a sale yet
Dec 8, 2025	FWP →	MARKETING	Free-writing prospectus — offering being marketed
Dec 8, 2025	424B5 →	EXECUTED	Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Dec 1, 2025	EFFECT →	EFFECTIVE	SEC declared a registration effective — selling can begin
Oct 6, 2025	S-3 →	REGISTERED	S-3 registration — capacity to sell shares, not a sale yet
Sep 8, 2025	8-K →	EXECUTED	Unregistered share sale disclosed (8-K item 3.02)
Jun 3, 2025	424B5 →	EXECUTED	Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
May 20, 2024	8-K →	EXECUTED	Unregistered share sale disclosed (8-K item 3.02)
Feb 7, 2024	424B5 →	EXECUTED	Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Feb 5, 2024	424B5 →	EXECUTED	Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Sep 28, 2023	EFFECT →	EFFECTIVE	SEC declared a registration effective — selling can begin
Sep 25, 2023	S-3 →	REGISTERED	S-3 registration — capacity to sell shares, not a sale yet
Aug 22, 2023	8-K →	EXECUTED	Unregistered share sale disclosed (8-K item 3.02)
Jul 14, 2023	424B5 →	EXECUTED	Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Mar 22, 2023	424B5 →	EXECUTED	Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Jan 18, 2023	8-K →	EXECUTED	Unregistered share sale disclosed (8-K item 3.02)
Jan 11, 2023	EFFECT →	EFFECTIVE	SEC declared a registration effective — selling can begin
Jan 3, 2023	S-3 →	REGISTERED	S-3 registration — capacity to sell shares, not a sale yet
Jul 19, 2022	RW →	WITHDRAWN	Registration withdrawn
May 27, 2022	S-1 →	REGISTERED	S-1 registration — capacity to sell shares, not a sale yet
May 27, 2022	FWP →	MARKETING	Free-writing prospectus — offering being marketed
Dec 17, 2021	424B4 →	EXECUTED	Final prospectus — offering priced (typical for IPOs and marketed share deals)
Dec 15, 2021	EFFECT →	EFFECTIVE	SEC declared a registration effective — selling can begin
Dec 1, 2021	FWP →	MARKETING	Free-writing prospectus — offering being marketed
Nov 4, 2021	S-1/A →	REGISTERED	S-1/A registration — capacity to sell shares, not a sale yet
Oct 28, 2021	S-1/A →	REGISTERED	S-1/A registration — capacity to sell shares, not a sale yet
Oct 15, 2021	S-1/A →	REGISTERED	S-1/A registration — capacity to sell shares, not a sale yet
Oct 6, 2021	S-1/A →	REGISTERED	S-1/A registration — capacity to sell shares, not a sale yet
Sep 17, 2021	S-1 →	REGISTERED	S-1 registration — capacity to sell shares, not a sale yet

IMMX offering-related filings from SEC EDGAR, newest first (capped at 40). Each links to the original document.

Two honest limits. (1) A 424B takedown can price shares or notes — EDGAR’s metadata doesn’t say which, so open the document: large investment-grade filers use these mostly for bond deals (no dilution), small-caps mostly for shares. (2) At-the-market (ATM) programs sell shares gradually and individual sales are not separately filed — the visible footprint is the enabling shelf and its 424B5; actual ATM share counts surface later in the 10-Q/10-K share count. Educational information from public filings, not investment advice.

Is a shelf active now? →Do they need money? →Red flags →Full IMMX workspace →

IMMX offering FAQ

When did IMMX last execute an offering?

Per SEC filings, Immix Biopharma, Inc.'s most recent priced offering document is a 424B5 filed 2026-09-29. Note a 424B takedown can price shares or notes (debt) — the linked document says which.

When did IMMX last announce or register an offering?

The most recent registration is a S-3 filed 2026-01-09. A registration is capacity to sell shares — not a sale.

Does an offering always mean dilution?

Registered direct offerings and shelf takedowns issue new shares and dilute existing holders. Resale registrations (424B3/B7) let existing holders sell and do not create new shares. Secondary sales by insiders also do not dilute. Each row here is labeled with what it is.

Free to use. No account, no card.